Vir Biotechnology Inc (VIR)

CapEx to Revenue

0.01%

Quarterly · Period ending:

VIR logo

VIR CapEx to Revenue

Latest reported0.01%
VIR Quarterly CapEx/Revenue (120.49% → 0.01%)
High-resolution chart · PNG

VIR capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vir Biotechnology Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.0134%
-1,344.8276%
6.9986%
132.0833%
209.061%
53.7269%
19.4521%
98.9916%
21.6585%
3.3206%
9.144%
140.7351%
249.0651%
10.9074%
25.4928%
5.0708%
-50.6978%
1.2853%
1.6078%
5.7964%
1.173%
33.7551%
140.1384%
76.4523%
2.0048%
22.7702%
158.3673%
89.5937%
129.702%
94.9467%
89.6033%
52.7903%
120.4853%
120.4853%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.